ask="N/A"
ask_size="N/A"
average_daily_volume="602695"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="+0.04"
change_from_200_day_moving_average="6.42"
change_from_50_day_moving_average="-2.23"
change_from_52_week_high="-15.84"
change_From_52_week_low="26.49"
change_in_percent="+0.05%"
close="73.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="75.39"
high_52_weeks="88.85"
last_trade_date="1/13/2017"
last_trade_price="73.01"
last_trade_size="31170"
last_trade_time="4:00pm"
low="72.42"
low_52_weeks="46.52"
market_capitalization="2.98B"
moving_average_200_day="66.59"
moving_average_50_day="75.24"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="72.93"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+9.65%"
percent_change_from_50_day_moving_average="-2.96%"
percent_change_from_52_week_high="-17.82%"
percent_change_from_52_week_low="+56.94%"
previous_close="72.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.41"
price_per_sales="23292.82"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="371415"
weeks_range_52="46.52 - 88.85"
